Cargando…
Human Islet Amyloid Polypeptide (hIAPP) Protofibril‐Specific Antibodies for Detection and Treatment of Type 2 Diabetes (Adv. Sci. 34/2022)
Type 2 Diabetes In article number 2202342, Ronald J. Parchem and co‐workers describe two hIAPP protofibril‐specific antibodies which prevent β cell toxicity in type 2 diabetes (T2D). Treatment with mAbs increases survival in a mouse model of severe T2D, and pancreatic islets from treated mice show d...
Autores principales: | Bortoletto, Angelina S., Graham, W. Vallen, Trout, Gabriella, Bonito‐Oliva, Alessandra, Kazmi, Manija A., Gong, Jing, Weyburne, Emily, Houser, Brandy L., Sakmar, Thomas P., Parchem, Ronald J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731679/ http://dx.doi.org/10.1002/advs.202270217 |
Ejemplares similares
-
Human Islet Amyloid Polypeptide (hIAPP) Protofibril‐Specific Antibodies for Detection and Treatment of Type 2 Diabetes
por: Bortoletto, Angelina S., et al.
Publicado: (2022) -
The NO Answer for Autism Spectrum Disorder (Adv. Sci. 22/2023)
por: Tripathi, Manish Kumar, et al.
Publicado: (2023) -
Designing Magnetism in High Entropy Oxides (Adv. Sci. 10/2022)
por: Mazza, Alessandro R., et al.
Publicado: (2022) -
Metasurface‐Programmable Wireless Network‐On‐Chip (Adv. Sci. 26/2022)
por: Imani, Mohammadreza F., et al.
Publicado: (2022) -
Superconductivity at Interfaces in Cuprate‐Manganite Superlattices (Adv. Sci. 21/2023)
por: Bonmassar, Nicolas, et al.
Publicado: (2023)